Interview with Tomas Luke Marcelo G. Agana III, President & CEO, PHAREX…
Mr. Agana, you have been in Pharex HealthCorp for more than twenty years. Can you give to our readers an overview of Pharex and what have been the main achievements…
Address: Units 101-102 G/F Building Alpha, P-AyalaLand TechnoHub, Commonwealth Avenue, Diliman, Quezon City,Philippines
Tel: (632) 433-8088
Web: http://www.pharexhealth.com/
PHAREX HealthCorp, a wholly-owned subsidiary of Pascual Laboratories, Inc., was formally established in April 1972 as the exclusive marketing, sales and distribution arm of Pascual Laboratories, Inc. (Pascuallab). As a matter of fact, PHAREX is short for Pharmaceutical Excellence – the very foundation on which the venture is built.
When Pascuallab formally appointed Metro Drug as its exclusive distributor of brands in 1987, PHAREX then secured the marketing of its generic medicines. The move was timely. Soon after, the Generics Act of 1988 was enforced.
Currently, distribution for PHAREX HealthCorp is handled by Zuellig Pharma.
PHAREX HealthCorp has maintained a strong presence in the Philippine generic pharmaceutical industry for over 20 years. Pioneers in the promotion of company or uni-branded medicines, PHAREX has since grown into one of the industry’s most trusted and prescribed brands.
PHAREX offers premium quality, affordable medicines to millions of Filipinos every day.
PHAREX continues to market products owned and manufactured by Pascuallab: this includes 34 products in 22 Therapeutic Categories, including Chronic Care and Wellness.
Mr. Agana, you have been in Pharex HealthCorp for more than twenty years. Can you give to our readers an overview of Pharex and what have been the main achievements…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Al Z. Castro, General Manager of IMS Health Philippines, speaks about the ongoing challenges of bringing about awareness and acceptance of generics medicine to the local population, how this will…
Ibrahim Monchito, Deputy Executive Director of the Department of Science and Technology ICT Office stresses the need to bring higher value to the HIM industry as a means to protect…
Pedro Miranda Jr., General Manager of Pacific Healthcare Philippines, talks about the decision to join Pacific Healthcare in the Philippines, how the company’s diversification strategy has evolved over the past…
Thelma Tobias–Go, President of the Philippine Chamber of the Pharmaceutical Industry and Scheele Laboartories, and Ed Ocampo, COO and Vice President of Scheele Laboratories, discuss the implications of the changing…
Jason Carroll, General Manager of Janssen Philippines, discusses what it will take to put Janssen Philippines on the map as one of the largest, most reputable pharmaceutical companies in the…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Marcelina Itchon, President & CEO of Aspen Philippines, talks about what drives Aspen’s success, why the Philippines was the first choice from which to build an Asian division, and the…
Romeo Carbonel, President & CEO of RBC-MDC Philippines, and Minerva Carbonel, COO of RBC-MDC, speak about how RBC-MDC was founded, its path to success since its founding, and whether or…
See our Cookie Privacy Policy Here
